Leveraging Electronic Health Records to Construct a Phenotype for Hypertension Surveillance in the United States
American Journal of Hypertension · 2023
DOI: 10.1093/ajh/hpad081 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hypertension, 2023. Verfasst von Siran He und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control an…. Hauptthemen laut MEDLINE: Antihypertensive Agents, Hypertension. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.
Abstract (Originalsprache)
BACKGROUND Hypertension is an important risk factor for cardiovascular diseases. Electronic health records (EHRs) may augment chronic disease surveillance. We aimed to develop an electronic phenotype (e-phenotype) for hypertension surveillance. METHODS We included 11,031,368 eligible adults from the 2019 IQVIA Ambulatory Electronic Medical Records-US (AEMR-US) dataset. We identified hypertension using three criteria, alone or in combination: diagnosis codes, blood pressure (BP) measurements, and antihypertensive medications. We compared AEMR-US estimates of hypertension prevalence and control against those from the National Health and Nutrition Examination Survey (NHANES) 2017–18, which defined hypertension as BP ≥130/80 mm Hg or ≥1 antihypertensive medication. RESULTS The study population had a mean (SD) age of 52.3 (6.7) years, and 56.7% were women. The selected three-criteria e-phenotype (≥1 diagnosis code, ≥2 BP measurements of ≥130/80 mm Hg, or ≥1 antihypertensive medication) yielded similar trends in hypertension prevalence as NHANES: 42.2% (AEMR-US) vs. 44.9% (NHANES) overall, 39.0% vs. 38.7% among women, and 46.5% vs. 50.9% among men. The pattern of age-related increase in hypertension prevalence was similar between AEMR-US and NHANES. The prevalence of hypertension control in AEMR-US was 31.5% using the three-criteria e-phenotype, which was higher than NHANES (14.5%). CONCLUSIONS Using an EHR dataset of 11 million adults, we constructed a hypertension e-phenotype using three criteria, which can be used for surveillance of hypertension prevalence and control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
- Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
- ASRT, INC, Smyrna, GA, USA.
- Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
ORCID-Profile: Siran He
Förderung
- Intramural CDC HHS
Zitieren
APA
He, S., Park, S., Kuklina, E., Therrien, N. L., Lundeen, E. A., Wall, H. K., Lampley, K., Kompaniyets, L., Pierce, S. L., Sperling, L., & Jackson, S. L. (2023). Leveraging Electronic Health Records to Construct a Phenotype for Hypertension Surveillance in the United States. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpad081
Vancouver
He S, Park S, Kuklina E, Therrien NL, Lundeen EA, Wall HK, et al. Leveraging Electronic Health Records to Construct a Phenotype for Hypertension Surveillance in the United States. American Journal of Hypertension. 2023. doi:10.1093/ajh/hpad081
BibTeX
@article{He2023,
author = {He, Siran and Park, Soyoun and Kuklina, Elena and Therrien, Nicole L and Lundeen, Elizabeth A and Wall, Hilary K and Lampley, Katrice and Kompaniyets, Lyudmyla and Pierce, Samantha L and Sperling, Laurence and Jackson, Sandra L},
title = {Leveraging Electronic Health Records to Construct a Phenotype for Hypertension Surveillance in the United States},
journal = {American Journal of Hypertension},
year = {2023},
doi = {10.1093/ajh/hpad081}
}
EUVIMED